NCT03955211 - HTX-011 Administration Study in Planned Caesarean Section Procedure | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 24, 2019

Primary Completion Date

December 3, 2021

Study Completion Date

December 27, 2021

Conditions

Analgesia

Interventions

DRUG

HTX-011

300 mg

DRUG

HTX-011

400 mg

DEVICE

Luer Lock Applicator

Applicator for instillation.

DRUG

Ibuprofen

400 mg

DRUG

Acetaminophen

975 mg to 1 g

Trial Locations (4)

UPMC Magee-Womens Hospital, Pittsburgh

Duke University Medical Center, Durham

Helen Keller Hospital, Sheffield

Sharp Mary Birch Hospital for Women and Newborns, San Diego